{"disease":{"id":"small-intestine-cancer","name":"Small intestine cancer","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"5-fu","indication_name":"Small intestine cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"5-fu","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"oxaliplatin","indication_name":"Small intestine cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eloxatin","generic_name":"Oxaliplatin","company_name":"Yakult Honsha","drug_phase":"marketed","molecular_target":"DNA","drug_class":"Platinum-based chemotherapy agent","quality_score":70,"revenue":null,"mechanism":"Oxaliplatin forms platinum-DNA crosslinks that inhibit replication and transcription."},{"drug_id":"fluorouracil","indication_name":"Small intestine cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"fluorouracil","company_name":"Extrovis","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"levofolinic-acid","indication_name":"Small intestine cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levoleucovorin","indication_name":"Small intestine cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03771508","title":"Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)","phase":"","overall_status":"COMPLETED","enrollment_count":3712,"lead_sponsor_name":"Medtronic - MITG","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT03345563","title":"Project HERO: Health Empowerment & Recovery Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT00003687","title":"Treatment for Chronic Pain in Patients With Advanced Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT04476082","title":"Nutrition in Gastrointestinal Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"University Medicine Greifswald","has_results":false},{"nct_id":"NCT03958188","title":"PreOPerative Imaging of NeuroEndocrine Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":47,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06582849","title":"Enhanced Assistance During Radiotherapy for Unmet Essential Needs","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT00569309","title":"Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT00416351","title":"Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT07060014","title":"NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":22,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false},{"nct_id":"NCT00003522","title":"Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Burzynski Research Institute","has_results":false},{"nct_id":"NCT00621036","title":"Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05471401","title":"GI Organ Tracking Via Balloon Applicators","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05450393","title":"Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GPS Study)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Medtronic - MITG","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}